These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 23373344)

  • 21. Cross-sector partnerships and public health: challenges and opportunities for addressing obesity and noncommunicable diseases through engagement with the private sector.
    Johnston LM; Finegood DT
    Annu Rev Public Health; 2015 Mar; 36():255-71. PubMed ID: 25581149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Public policy and private sector provision of health services.
    Rosenthal G; Newbrander W
    Int J Health Plann Manage; 1996; 11(3):203-16. PubMed ID: 10162428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. South Korean biotechnology--a rising industrial and scientific powerhouse.
    Wong J; Quach U; Thorsteinsdóttir H; Singer PA; Daar AS
    Nat Biotechnol; 2004 Dec; 22 Suppl():DC42-7. PubMed ID: 15583684
    [No Abstract]   [Full Text] [Related]  

  • 24. The emergence of Egyptian biotechnology from generics.
    Abdelgafar B; Thorsteinsdóttir H; Quach U; Singer PA; Daar AS
    Nat Biotechnol; 2004 Dec; 22 Suppl():DC25-30. PubMed ID: 15583680
    [No Abstract]   [Full Text] [Related]  

  • 25. Building a new health system: implications for public health management and practice.
    O'Brien MJ
    J Public Health Manag Pract; 1995; 1(3):29-34. PubMed ID: 10186620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Public-private partnerships for hospitals.
    McKee M; Edwards N; Atun R
    Bull World Health Organ; 2006 Nov; 84(11):890-6. PubMed ID: 17143463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A public health perspective on healthy lifestyles and public-private partnerships for global childhood obesity prevention.
    Kraak VI; Story M
    J Am Diet Assoc; 2010 Feb; 110(2):192-200. PubMed ID: 20102845
    [No Abstract]   [Full Text] [Related]  

  • 28. Nordic privatization and private healthcare.
    Ovretveit J
    Int J Health Plann Manage; 2003; 18(3):233-46. PubMed ID: 12968800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Entrepreneurs ' perspective on public-private partnership in health care and social services.
    Sinisammal J; Leviäkangas P; Autio T; Hyrkäs E
    J Health Organ Manag; 2016; 30(1):174-91. PubMed ID: 26964856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Development of entrepreneurship in the field of medical care based on the franchising model].
    Lomakina NF
    Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med; 2020 Aug; 28(Special Issue):766-772. PubMed ID: 32856823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Public Private Partnership (PPP) for essential health services. An innovative approach for optimum and efficient use of public and private resources.
    Azam M
    World Hosp Health Serv; 2003; 39(1):1. PubMed ID: 12743880
    [No Abstract]   [Full Text] [Related]  

  • 32. Case management lessons from a public/private partnership to finance long-term care.
    Mahoney K
    J Case Manag; 1992; 1(1):22-5, 35. PubMed ID: 1467793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Control of tuberculosis in an urban setting in Nepal: public-private partnership.
    Newell JN; Pande SB; Baral SC; Bam DS; Malla P
    Bull World Health Organ; 2004 Feb; 82(2):92-8. PubMed ID: 15042230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Privatization and the allure of franchising: a Zambian feasibility study.
    Fiedler JL; Wight JB
    Int J Health Plann Manage; 2003; 18(3):179-204. PubMed ID: 12968797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Public-private health partnerships: a strategy for WHO.
    Buse K; Waxman A
    Bull World Health Organ; 2001; 79(8):748-54. PubMed ID: 11545332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [On the issue of enhancement of public health normative legal base of Voronejskaya oblast].
    Ivanov MV; Shchepin VO
    Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med; 2011; (6):28-31. PubMed ID: 22611984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The development of China's medical biotech industry needs to be driven by innovation.
    Yu Z; Dai Y
    Biotechnol J; 2006 Nov; 1(11):1253-7. PubMed ID: 17068752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Main aspects of state control of the sanatorium and resort market].
    Razumov AN; Limonov VI; Semenov BN
    Vopr Kurortol Fizioter Lech Fiz Kult; 2003; (1):4-9. PubMed ID: 12698699
    [No Abstract]   [Full Text] [Related]  

  • 39. Is the practice of public or private sector doctors more evidence-based? A qualitative study from Vellore, India.
    Akinyemi OO; Martineau T; Tharyan P
    Int J Evid Based Healthc; 2015 Jun; 13(2):66-76. PubMed ID: 26057650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How shall we examine and learn about public-private partnerships (PPPs) in the health sector? Realist evaluation of PPPs in Hong Kong.
    Wong EL; Yeoh EK; Chau PY; Yam CH; Cheung AW; Fung H
    Soc Sci Med; 2015 Dec; 147():261-9. PubMed ID: 26605970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.